Down-regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease. (Q48696116)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27258819%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

title

Down-regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27258819%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27258819%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Maria Javier Ramírez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27258819%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Maite Solas

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27258819%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Francisco J Gil-Bea

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27258819%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Gorka Gerenu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27258819%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

author name string

Manuel Rodriguez-Perdigon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27258819%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

publication date

21 June 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27258819%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27258819%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27258819%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

page(s)

1303-1312

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27258819%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27258819%20AND%20SRC:MED&resulttype=core&format=json

Age-dependent impairment of spine morphology and synaptic plasticity in hippocampal CA1 neurons of a presenilin 1 transgenic mouse model of Alzheimer's disease.

3 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Altered synaptic function in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Paradoxical upregulation of glutamatergic presynaptic boutons during mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Predominant loss of glutamatergic terminal markers in a β-amyloid peptide model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

The neurotransmitter cycle and quantal size

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Increased vulnerability to depressive-like behavior of mice with decreased expression of VGLUT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Synaptic and vesicular co-localization of the glutamate transporters VGLUT1 and VGLUT2 in the mouse hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Vesicular glutamate transporter and cognition in stroke: a case-control autopsy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Widespread changes in dendritic spines in a model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-β

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Synaptic targeting by Alzheimer's-related amyloid beta oligomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Psychosis of Alzheimer's disease is associated with elevated muscarinic M2 binding in the cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

The human brain revisited: opportunities and challenges in postmortem studies of psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Abnormal glutamate transport function in mutant amyloid precursor protein transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

The cholinergic lesion of Alzheimer's disease: pivotal factor or side show?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Altered synapses and gliotransmission in Alzheimer's disease and AD model mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Alzheimer's disease-related amyloid-β induces synaptotoxicity in human iPS cell-derived neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Reduction in post-synaptic scaffolding PSD-95 and SAP-102 protein levels in the Alzheimer inferior temporal cortex is correlated with disease pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Perforant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-old

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Lipoic acid improves neuronal insulin signalling and rescues cognitive function regulating VGlut1 expression in high-fat-fed rats: Implications for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Orchestrated experience-driven Arc responses are disrupted in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Reduced hippocampal glutamate in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer's disease cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer's disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Enhanced anxiety, depressive-like behaviour and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (VGLUT1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

Inflammation in neurodegenerative disease--a double-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

inferred from DOI database lookup

7 January 2021

based on heuristic

Interactions between age, stress and insulin on cognition: implications for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

inferred from DOI database lookup

7 January 2021

based on heuristic

Cerebral level of vGlut1 is increased and level of glycine is decreased in TgSwDI mice.

1 reference

https://api.crossref.org/works/10.1002%2FHIPO.22607

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HIPO.22607

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27258819%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

1 reference